Nuvation Bio Inc.
NUVB
$4.44
-$0.07-1.44%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 41.87M | 13.12M | 4.83M | 3.08M | 5.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 41.87M | 13.12M | 4.83M | 3.08M | 5.71M |
| Cost of Revenue | 1.28M | 3.35M | 2.58M | 2.09M | 4.22M |
| Gross Profit | 40.59M | 9.77M | 2.26M | 990.00K | 1.50M |
| SG&A Expenses | 40.33M | 37.36M | 38.48M | 35.39M | 26.14M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 75.90M | 69.55M | 68.42M | 62.09M | 59.65M |
| Operating Income | -34.04M | -56.43M | -63.59M | -59.00M | -53.94M |
| Income Before Tax | -36.59M | -55.79M | -59.01M | -53.24M | -49.45M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -36.59M | -55.79M | -59.01M | -53.24M | -49.45M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.59M | -55.79M | -59.01M | -53.24M | -49.45M |
| EBIT | -34.04M | -56.43M | -63.59M | -59.00M | -53.94M |
| EBITDA | -33.50M | -55.90M | -63.23M | -58.69M | -53.72M |
| EPS Basic | -0.11 | -0.16 | -0.17 | -0.16 | -0.15 |
| Normalized Basic EPS | -0.07 | -0.10 | -0.11 | -0.10 | -0.09 |
| EPS Diluted | -0.11 | -0.16 | -0.17 | -0.16 | -0.15 |
| Normalized Diluted EPS | -0.07 | -0.10 | -0.11 | -0.10 | -0.09 |
| Average Basic Shares Outstanding | 344.34M | 342.39M | 340.75M | 338.61M | 336.93M |
| Average Diluted Shares Outstanding | 344.34M | 342.39M | 340.75M | 338.61M | 336.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |